
Shree Mahaveer Pharma-Tech And Drugs Private Limited
Pharmaceutical distributor company with registered office in Orissa.
Pharmaceutical distributor company with registered office in Orissa.
Shree Mahaveer Pharma-Tech And Drugs Private Limited (SMPADPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 22 February 2011 and has a history of 14 years and two months. Its registered office is in Khorda, Odisha, India.
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 4.50 M.
The company currently has active open charges totaling ₹2.69 Cr. The company has closed loans amounting to ₹1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Rudra Behera, Rudra Hota, and Prabhasini Sahoo serve as directors at the Company.
Khorda, Odisha, India
+91-XXXXXXXXXX
U51397OR2011PTC013196
013196
Private Limited Indian Non-Government Company
22 Feb 2011
30 Sep 2023
31 Mar 2023
Unlisted
Roc Cuttack
Name | Designation | Appointment Date | Status |
---|---|---|---|
Rudra Behera ![]() | Director | 22-Feb-2011 | Current |
Rudra Hota ![]() | Additional Director | 10-Jan-2024 | Current |
Prabhasini Sahoo ![]() | Director | 28-Mar-2014 | Current |
Shree Mahaveer Pharma-Tech And Drugs Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 27.24% increase. The company also saw a substantial improvement in profitability, with a 63.13% increase in profit. The company's net worth moved up by a moderate rise of 6.22%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
In 2023, Shree Mahaveer Pharma-Tech And Drugs had a promoter holding of 78.89% and a public holding of 21.11%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Rudra Behera is a mutual person
Rudra Behera is a mutual person
Rudra Hota is a mutual person
Rudra Hota is a mutual person
Rudra Hota is a mutual person
Rudra Hota is a mutual person
₹26.95 M
₹1.00 M
Date | Lender | Amount | Status |
---|---|---|---|
22 Sep 2022 | Hdfc Bank Limited | ₹1.55 M | Open |
15 Jan 2022 | Hdfc Bank Limited | ₹0.70 M | Open |
29 Oct 2020 | Others | ₹3.70 M | Open |
29 Sep 2018 | Canara Bank | ₹1.50 M | Open |
05 May 2014 | Canara Bank | ₹1.95 Cr | Open |
Unlock and access historical data on people associated with Shree Mahaveer Pharma-Tech And Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Shree Mahaveer Pharma-Tech And Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shree Mahaveer Pharma-Tech And Drugs's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Rudra Prasana Hota was appointed as a Additional Director was appointed as a Additional Director on 10 Jan 2024 & has been associated with this company since 1 year 4 months .
Shree Mahaveer Pharma-Tech And Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
Shree Mahaveer Pharma-Tech And Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Cuttack.
A charge with Hdfc Bank Limited amounted to Rs. 1.55 M with Charge ID 100664879 was registered on 22 Sep 2022.
A charge with Hdfc Bank Limited amounted to Rs. 0.70 M with Charge ID 100542248 was registered on 15 Jan 2022.
A charge with Others amounted to Rs. 3.70 M with Charge ID 100396054 was registered on 29 Oct 2020.
Shree Mahaveer Pharma-Tech And Drugs Private Limited was incorporated on 22 Feb 2011.
The authorized share capital of Shree Mahaveer Pharma-Tech And Drugs Private Limited is ₹ 5.00 M and paid-up capital is ₹ 4.50 M.
Currently 3 directors are associated with Shree Mahaveer Pharma-Tech And Drugs Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Shree Mahaveer Pharma-Tech And Drugs Private Limited is Plot No-974(B) Ground Floor Park Street, New Forest India, Bhubaneswar, Orissa, 751009.
The corporate identification number (CIN) of Shree Mahaveer Pharma-Tech And Drugs Private Limited is U51397OR2011PTC013196 and the company number is 013196 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2023, the revenue trend for Shree Mahaveer Pharma-Tech And Drugs Private Limited has risen by 27.24%.
The financial reports for the fiscal year 2023 indicates that The net worth of Shree Mahaveer Pharma-Tech And Drugs Private Limited has experienced an upsurge of 6.22%.
As per the financial statements for fiscal Year 2023, The total open charges for Shree Mahaveer Pharma-Tech And Drugs Private Limited amount to ₹ 2.69 Cr.
The most recent Balance Sheet for Shree Mahaveer Pharma-Tech And Drugs Private Limited was filed with the ROC on 31 Mar 2023.
Search company & director profiles for free and gain access to critical business data.
DS
PB
BG
DD